RANDOMIZED PHASE II TRIAL OF NGR-HTNF AND CHEMOTHERAPY IN CHEMO-NAIVE PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY RESULTS.

被引：0
|
作者：
Gregorc, Vanesa [1 ]
Zilembo, N. [2 ]
Grossi, Francesco
Rossoni, Gilda [1 ]
Pietrantonio, Filippo [2 ]
Rijavec, Erika
Bulotta, Alessandra [1 ]
Vitali, Milena [2 ]
Barletta, Giulia
Bergamaschi, Luca [2 ]
Platania, Marco [2 ]
Lambiase, Antonio
Bordignon, Claudio
机构：
[1] Ist Sci San Raffaele, Dept Oncol, Milan, Italy
[2] Ist Nazl Tumori, Naples, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; Chemotherapy; NGR-hTNF;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S661 / S662
页数：2
相关论文
共 50 条
  • [41] Combination therapy of envafolimab and suvemcitug with chemotherapy in patients with non-small cell lung cancer (NSCLC): Results from a phase II clinical trial
    Wu, C.
    Wu, L.
    Meng, X.
    Wang, Y.
    Fan, Q.
    Wang, X.
    Gu, K.
    Ma, R.
    Hu, C.
    Lu, L.
    Su, F.
    Yang, C.
    Liu, Z.
    Tian, J.
    Sun, X.
    Sun, S.
    Cheng, Y.
    ANNALS OF ONCOLOGY, 2023, 34
  • [42] A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC)
    Grigorescu, Alexandru
    Ciuleanu, Tudor
    Firoiu, Elena
    Muresan, Delia Ruta
    Teodorescu, Gabriela
    Basson, Bruce R.
    LUNG CANCER, 2007, 57 (02) : 168 - 174
  • [43] A phase 1/2 study of STA-4783 in combination with paclitaxel and carboplatin in chemo-naive advanced non-small cell lung cancer (NSCLC).
    Jacobs, M
    Weber, R
    Hainsworth, J
    Schwartzberg, L
    Strauss, J
    Tatsuta, N
    Du, Z
    McLeod, M
    Dahl, T
    Salgia, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 646S - 646S
  • [44] TOPICAL: Randomized phase III trial of erlotinib compared with placebo in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC) and unsuitable for firstline chemotherapy
    Lee, S.
    Rudd, R.
    Khan, I.
    Upadhyay, S.
    Lewanski, C. R.
    Falk, S.
    Skailes, G.
    Partridge, R.
    Ngai, Y.
    Boshoff, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Interim results of a phase II study of docetaxel (Taxotere(R)) in unresectable non-small cell lung cancer (NSCLC) on 204 chemotherapy naive or pretreated patients
    Mattson, K
    LeChevalier, T
    Bosquee, L
    Pujol, JL
    Culine, S
    Dabouis, G
    LeGroumellec, A
    Stupp, R
    Boyer, R
    Berille, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1036 - 1036
  • [46] Nazartinib (EGF816) in patients with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC): Updated phase II results.
    Tan, Daniel Shao-Weng
    Leighl, Natasha B.
    Yang, James Chih-Hsin
    Riely, Gregory J.
    Sequist, Lecia, V
    Toyozawa, Ryo
    Wolf, Juergen
    Felip, Enriqueta
    Kim, Sang-We
    Aix, Santiago Ponce
    Smit, Egbert F.
    Hida, Toyoaki
    Grohe, Christian
    Ghebremariam, Samson
    O'Sullivan-Djentuh, Leslie
    Belli, Riccardo
    Giovannini, Monica
    Kim, Dong-Wan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] RANDOMIZED TRIAL OF ORAL VERAPAMIL WITH CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER (NSCLC)
    MILLWARD, MJ
    CORRIS, PA
    HARRIS, AL
    CANTWELL, BMJ
    BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 450 - 450
  • [48] Neoadjuvant chemotherapy vs, radiotherapy alone for superior vena cava syndrome (SVCS) due to non-small cell lung cancer (NSCLC): Preliminary results of randomized phase II trial
    Pereira, JR
    Martins, SJ
    Ikari, FK
    Nikaedo, SM
    Gampel, O
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S260 - S260
  • [49] BEVACIZUMAB BEYOND PROGRESSION IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY RESULTS OF A PHASE II STUDY
    Timmer-Bonte, Johanna N. H.
    Van den Hurk, Desiree G. M.
    Dohmen, Miriam A.
    Smits-Vandergraaf, Chantal A.
    Van der Drift, Miep
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1255 - S1256
  • [50] A phase II trial of combination chemotherapy with irinotecan and amrubicin in pretreated patients with non-small cell lung cancer (NSCLC): Results of Okayama Lung Cancer Study Group Trial 0402
    Kuyama, S.
    Segawa, Y.
    Nogami, N.
    Kiura, K.
    Takigawa, N.
    Shibayama, T.
    Hosokawa, S.
    Aoe, K.
    Tabata, M.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345